Amorfix and Ontario Genomics Institute announce partnership to accelerate development of blood test for Alzheimer's Disease
02-Feb-2006 -
Amorfix Life Sciences Inc. and the Ontario Genomics Institute (OGI) announced they are entering into a partnership to develop a blood test for Alzheimer's disease, EP-AD(TM), based upon Amorfix's patent-pending Epitope Protection technology. OGI will assist Amorfix in accelerating its program for ...
Alzheimer's disease
blood tests
diseases
+3